Receptor mediated subversion of macrophage cytokine production by intracellular pathogens

Current Opinion in Immunology

Volumn 11, Issue 4, 1999, Pages 406-411

  Mosser, David M ^a   Karp, Christopher L ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE; INTERLEUKIN 12;

CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HISTOPLASMA CAPSULATUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; LEISHMANIA; MACROPHAGE; MEASLES VIRUS; NONHUMAN; REVIEW;

EID: 0033179608     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80068-5     Document Type: Article

References (34)

1. McFadden G, Lalani A, Everett H, Nash P, Xu X: Virus-encoded receptors for cytokines and chemokines. Semin Cell Dev Biol 1998, 9:359-368.
2. Knutson KL, Hmama Z, Herrera-Velit P, Rochford R, Reiner NE: Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes. Role of the Src homology 2 containing tyrosine phosphatase 1. J Biol Chem 1998, 273:645-652.
3. Dahl KE, Shiratsuchi H, Hamilton BD, Ellner JJ, Toossi Z: Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect Immun 1996, 64:399-405.
4. Schesser K, Spiik AK, Dukuzumuremyi JM, Neurath MP, Pettersson S, Wolf-Watz H: The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol Microbiol 1998, 28:1067-1079. A convincing demonstration that a single gene product from a bacterium can specifically influence signaling in eukaryotic cells.
5. Miskin JE, Abrams CC, Goatley LC, Dixon LK: A viral mechanism for inhibition of the cellular phosphatase calcineurin. Science 1998, 281:562-565.
6. Trinchieri G: Interleukin-12: A cytokine at the interface of inflammation and immunity. Adv Immunol 1998, 70:83-243. An excellent and comprehensive discussion of IL-12.
7. Karp CL, Wysocka M, Ma X, Marovitch M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchier G: Potent suppression of II-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol 1998, 28:3128-3136.
8. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE: Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996, 273:228-231.
9. Marth T, Kelsall BL: Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med 1997, 185:1987-1995.
10. Sutterwala FS, Noel GJ, Clynes R, Mosser DM: Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med 1997, 185:1977-1985.
11. Fearon DT, Carter RH: The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity. Annu Rev Immunol 1995, 13:127-149.
12. Berger S, Chandra R, Ballo H, Hildenbrand R, Stutte HJ: Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes. Eur J Immunol 1997, 27:2994-3000.
13. Sutterwala FS, Noel GJ, Salgame P, Mosser DM: Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med 1998, 188:217-222. This work was the first to formally show that the ligation of one of the FcyRs could specifically induce the production of IL-10 in response to low levels of inflammatory stimuli.
14. Liszewski MK, Post TW, Atkinson JP: Membrane cofactor protein (MCP or CD46): Newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 1991, 9:431-455.
15. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan MC, Liu YJ, Rabourdin-Combe C: Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997, 186:813-823.
16. Zhou P, Sieve MC, Bennett J, Kwon-Chung KJ, Tewari RP, Gazzinelli RT, Sher A, Seder RA: IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J Immunol 1995, 155:785-795.
17. Bullock WE, Wright SD: Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J Exp Med 1987, 165:195-210.
18. Reiner SL, Locksley RM: The regulation of immunity to Leishmania major. Annu Rev Immunol 1995, 13:151-177.
19. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Muller W, Kuhn R, Sacks DL: Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 1996, 183:515-526.
20. Belkaid Y, Butcher B, Sacks DL: Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: Selective impairment of IL-12 induction in Leishmania-infected cells. Eur J Immunol 1998, 28:1389-1400.
21. von Stebut E, Belkaid Y, Jakob T, Sacks DL, Udey MC: Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: Implications for the initiation of anti-Leishmania immunity. J Exp Med 1998, 188:1547-1552. This work suggests that fundamental differences between dendritic cells and macrophages may exist with regard to the regulation of IL-12 production in response to infectious stimuli.
22. Weinheber N, Wolfram M, Harbecke D, Aebischer T: Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur J Immunol 1998, 28:2467-2477.
23. Guy RA, Belosevic M: Comparison of receptors required for entry of Leishmania major amastigotes into macrophages. Infect Immun 1993, 61:1553-1558.
24. Karp CL, el-Safi SH, Wynn TA, Satti MM, Kordofani AM, Hashim FA, Hag-Ali M, Neva FA, Nutman TB, Sacks DL: In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest 1993, 91:1644-1648.
25. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G: Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994, 179:1361-1366.
26. Chougnet C, Wynn TA, Clerici M, Landay AL, Kessler HA, Rusnak J, Melcher GP, Sher A, Shearer GM: Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis 1996, 174:46-53.
27. Gazzinelli RT, Bala S, Stevens R, Baseler M, Wahl L, Kovacs J, Sher A: HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. J Immunol 1995, 155:1565-1574.
28. Denis M, Ghadirian E: Dysregulation of interteukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res Hum Retroviruses 1994, 10:1619-1627.
29. Aste-Amezaga M, Ma X, Sartori A, Trinchieri G: Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol 1998, 160:5936-5944.
30. Marshall JD, Robertson SE, Trinchieri G, Chehimi J: Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients. J Immunol 1997, 159:5705-5714.
31. Cousens LP, Orange JS, Su HC, Biron CA: Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci USA 1997, 94:634-639.
32. Meyaard L, Hovenkamp E, Pakker N, van der Pouw Kraan TC, Miedema F: Interleukin-12 (IL-12) production in whole blood cultures from human immunodeficiency virus-infected individuals studied in relation to IL-10 and prostaglandin E2 production. Blood 1997, 89:570-576.
33. Dierich MP, Ebenbichler CF, Marschang P, Fust G, Thielens NM, Arland GJ: HIV and human complement: Mechanisms of interaction and biological implication. Immunol Today 1993, 14:435-440.
34. Stoiber H, Frank I, Spruth M, Schwendinger M, Mullauer B, Windisch JM, Schneider R, Katinger H, Ando I, Dierich MP: Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): An accessory role for CR3 during virus entry? Mol Immunol 1997, 34:855-863.